Wijdenes J - Search Results

1

Immunotoxins constructed with anti-CD25 monoclonal antibodies and deglycosylated ricin A-chain have potent anti-tumour effects against human Hodgkin cells in vitro and solid Hodgkin tumours in mice.

Engert A, Martin G, Amlot P, Wijdenes J, Diehl V, Thorpe P. Engert A, et al. Among authors: wijdenes j. Int J Cancer. 1991 Sep 30;49(3):450-6. doi: 10.1002/ijc.2910490324. Int J Cancer. 1991. PMID: 1917143

2

Enhanced antitumor effects of CD20 over CD19 monoclonal antibodies in a nude mouse xenograft model.

Hooijberg E, van den Berk PC, Sein JJ, Wijdenes J, Hart AA, de Boer RW, Melief CJ, Hekman A. Hooijberg E, et al. Among authors: wijdenes j. Cancer Res. 1995 Feb 15;55(4):840-6. Cancer Res. 1995. PMID: 7531616

3

Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma.

Blay JY, Rossi JF, Wijdenes J, Menetrier-Caux C, Schemann S, Négrier S, Philip T, Favrot M. Blay JY, et al. Among authors: wijdenes j. Int J Cancer. 1997 Jul 29;72(3):424-30. doi: 10.1002/(sici)1097-0215(19970729)72:3<424::aid-ijc9>3.0.co;2-r. Int J Cancer. 1997. PMID: 9247285 Clinical Trial.

4

Efficacy and toxicity of plasma-cell-reactive monoclonal antibodies B-B2 and B-B4 and their immunotoxins.

Vooijs WC, Post J, Wijdenes J, Schuurman HJ, Bolognesi A, Polito L, Stirpe F, Bast EJ, de Gast GC. Vooijs WC, et al. Among authors: wijdenes j. Cancer Immunol Immunother. 1996 Jul;42(6):319-28. doi: 10.1007/s002620050289. Cancer Immunol Immunother. 1996. PMID: 8830734 Free PMC article.

5

Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody.

Beck JT, Hsu SM, Wijdenes J, Bataille R, Klein B, Vesole D, Hayden K, Jagannath S, Barlogie B. Beck JT, et al. Among authors: wijdenes j. N Engl J Med. 1994 Mar 3;330(9):602-5. doi: 10.1056/NEJM199403033300904. N Engl J Med. 1994. PMID: 8302342 Free article. No abstract available.

6

Human anti-mouse antibody response to the injection of murine monoclonal antibodies against IL-6.

Legouffe E, Liautard J, Gaillard JP, Rossi JF, Wijdenes J, Bataille R, Klein B, Brochier J. Legouffe E, et al. Among authors: wijdenes j. Clin Exp Immunol. 1994 Nov;98(2):323-9. doi: 10.1111/j.1365-2249.1994.tb06145.x. Clin Exp Immunol. 1994. PMID: 7955540 Free PMC article.

7

Monoclonal antibodies specific for the IL-18 receptor.

Vermot-Desroches C, Subiger O, Guenot F, Sergent E, Bonnin B, Wijdenes J. Vermot-Desroches C, et al. Among authors: wijdenes j. Cell Immunol. 2005 Jul-Aug;236(1-2):101-4. doi: 10.1016/j.cellimm.2005.08.014. Epub 2005 Sep 12. Cell Immunol. 2005. PMID: 16157318

8

A semi-pharmaceutical approach for the preparation of an anti-IL2 receptor monoclonal antibody in the treatment of acute GvHD in a multicentric study.

Wijdenes J, Beliard R, Muot S, Herve P, Peters A. Wijdenes J, et al. Dev Biol Stand. 1990;71:103-11. Dev Biol Stand. 1990. PMID: 2205522 Clinical Trial.

9

B-B10 (anti-CD25)-saporin immunotoxin--a possible tool in graft-versus-host disease treatment.

Tazzari PL, Bolognesi A, De Totero D, Pileri S, Conte R, Wijdenes J, Hervé P, Soria M, Stirpe F, Gobbi M. Tazzari PL, et al. Among authors: wijdenes j. Transplantation. 1992 Aug;54(2):351-6. doi: 10.1097/00007890-199208000-00029. Transplantation. 1992. PMID: 1496546

10

Monoclonal antibodies in human organ transplantation and auto-immune diseases.

Wijdenes J, Roy C, Morel-Fourrier B, Racadot E. Wijdenes J, et al. Therapie. 1992 Jul-Aug;47(4):283-7. Therapie. 1992. PMID: 1494788 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters